Early Stem Cell Transplantation for Chronic Lymphocytic Leukaemia
Author Information
Author(s): P Dreger, N von Neuhoff, R Kuse, R Sonnen, B Glass, L Uharek, R Schoch, H Loffler, N Schmitz
Primary Institution: Second Department of Medicine, University of Kiel
Hypothesis
Can early stem cell transplantation improve the prognosis for patients with chronic lymphocytic leukaemia?
Conclusion
Sequential high-dose therapy using Dexa-BEAM and autologous stem cell transplantation is a safe and highly effective treatment for patients with chronic lymphocytic leukaemia.
Supporting Evidence
- 16 out of 18 patients achieved minimal disease after treatment.
- All patients showed a clone-specific molecular marker.
- Procedure-related deaths did not occur.
Takeaway
Doctors are trying a new way to treat a type of blood cancer called chronic lymphocytic leukaemia by using special cells from the patients' own blood to help them get better.
Methodology
Patients received Dexa-BEAM chemotherapy to mobilize stem cells, followed by high-dose therapy and stem cell reinfusion, with monitoring for minimal residual disease using PCR.
Limitations
The study had a small sample size and a short follow-up period.
Participant Demographics
Median age was 49 years, with 5 females and 13 males; included patients with early and advanced stages of the disease.
Want to read the original?
Access the complete publication on the publisher's website